Meeting to be held in New York on March 5 hosted by Lake Street.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RCEL:
- Avita Medical price target lowered to $22 from $25 at D. Boral Capital
- Avita Medical’s Growth Potential and Strategic Expansion: Analyst Josh Jennings Reiterates Buy Rating
- AVITA Medical Reports Transformative Year Amidst Challenges
- Avita Medical price target lowered to $11 from $12 at Piper Sandler
- AVITA Medical Reports Revenue Growth Amid New Product Approvals